These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 23255242)

  • 1. Major adverse cardiovascular events and mortality in systemic lupus erythematosus patients after successful delivery: a population-based study.
    Wu LS; Tang CH; Lin YS; Lin CP; Hung ST; Hwa HL; Luo SF; Chu PH
    Am J Med Sci; 2014 Jan; 347(1):42-9. PubMed ID: 23255242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus women with delivery with higher risk of heart failure compared with those without pregnancy but neutral in major adverse cardiovascular events. A population-based matched cohort study.
    Wu LS; Liu PH; Lin YS; Lin CP; Chang CJ; Chu PH
    Clin Exp Rheumatol; 2014; 32(1):108-12. PubMed ID: 24387950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of coronary artery bypass grafting in patients with inflammatory rheumatic diseases: an 11-year nationwide cohort study.
    Lai CH; Lai WW; Chiou MJ; Tsai LM; Wen JS; Li CY
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):859-66.e1-2. PubMed ID: 25541410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea.
    Lim SY; Bae EH; Han KD; Jung JH; Choi HS; Kim HY; Kim CS; Ma SK; Kim SW
    Lupus; 2018 Nov; 27(13):2050-2056. PubMed ID: 30282562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal-placental syndrome and future risk of accelerated cardiovascular events in Parous Swedish women with systemic lupus erythematosus - a population-based retrospective cohort study with time-to-event analysis.
    Soh MC; Dib F; Nelson-Piercy C; Westgren M; McCowan L; Pasupathy D
    Rheumatology (Oxford); 2016 Jul; 55(7):1235-42. PubMed ID: 27016663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.
    Manzi S; Meilahn EN; Rairie JE; Conte CG; Medsger TA; Jansen-McWilliams L; D'Agostino RB; Kuller LH
    Am J Epidemiol; 1997 Mar; 145(5):408-15. PubMed ID: 9048514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
    Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
    Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.
    Ward MM
    Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pre-eclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan.
    Lin YS; Tang CH; Yang CY; Wu LS; Hung ST; Hwa HL; Chu PH
    Am J Cardiol; 2011 Jan; 107(2):325-30. PubMed ID: 21211611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
    Yu HH; Chen PC; Yang YH; Wang LC; Lee JH; Lin YT; Chiang BL
    Atherosclerosis; 2015 Nov; 243(1):11-8. PubMed ID: 26342937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies.
    Lin CY; Shih CC; Yeh CC; Chou WH; Chen TL; Liao CC
    Int J Cardiol; 2014 Oct; 176(3):847-51. PubMed ID: 25156834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: a nationwide population-based study in Taiwan.
    Chen YM; Lin CH; Chen HH; Chang SN; Hsieh TY; Hung WT; Hsieh CW; Lai KL; Lan JL; Chen DY; Lan TH
    Rheumatology (Oxford); 2014 Jan; 53(1):180-5. PubMed ID: 24136069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
    Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
    Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
    Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
    J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.
    Barbhaiya M; Feldman CH; Guan H; Gómez-Puerta JA; Fischer MA; Solomon DH; Everett B; Costenbader KH
    Arthritis Rheumatol; 2017 Sep; 69(9):1823-1831. PubMed ID: 28598016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.
    Lai CH; Lai WW; Chiou MJ; Lin WC; Yang YJ; Li CY; Tsai LM
    Ann Rheum Dis; 2016 Jul; 75(7):1350-6. PubMed ID: 26286017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
    Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
    Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.
    Hermansen ML; Lindhardsen J; Torp-Pedersen C; Faurschou M; Jacobsen S
    Rheumatology (Oxford); 2017 May; 56(5):709-715. PubMed ID: 28053276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.